← Leaderboards
Alison Edelman
Oregon Health & Science University
$1,129,796
Attributed
$1,129,796
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $386.6K · FY2015–24$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,129,796 · 2
By mechanism
N01$1,129,796 · 2
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Jeffrey Jensen$3,882,169
- Alison B Edelman$5,115,754
- Steffani R Bailey$5,604,356
- Larry S. Sherman$10,263,725
- Jae Downing$257,603
Others in their field
Top investigators on “Enrollment”
- Jeffrey P Krischer · University Of South Florida$370,021,822
- Lawrence Corey · Fred Hutchinson Cancer Center$329,293,433
- David R. Weir · University Of Michigan At Ann Arbor$265,368,888
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$231,949,330
- James Dennis Neaton · Northwestern University$218,104,551
- George R Seage · Abt Associates, Inc.$205,403,788
Research focus
EnrollmentHormonesContraceptive MethodsWomanRecording Of Previous EventsProtocols DocumentationNational Institute Of Child Health And Human DevelopmentReproductiveClinical Trials NetworkContraceptive AgentsSafetyIntrauterine DevicesContraceptive EfficacyRecruitVenous ThromboembolismLactationEstrogensLaboratoriesLevonorgestrelDrug KineticsInjectableBody Mass IndexClinical TrialsImplant
Grant awards (7)
CENTRAL LABORATORY FOR PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$95,077
N01 · FY2024 · HD · contact PI
CENTRAL LABORATORY FOR PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$199,076
N01 · FY2023 · HD · contact PI
CENTRAL LABORATORY FOR PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$30,073
N01 · FY2022 · HD · contact PI
CENTRAL LABORATORY FOR PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$120,567
N01 · FY2021 · HD · contact PI
CCTN - CLINICAL EVALUATION OF LONG ACTING REVERSIBLE CONTRACEPTIVES$228,654
N01 · FY2020 · HD · contact PI
CCTN - CLINICAL EVALUATION OF LONG ACTING REVERSIBLE CONTRACEPTIVES$69,726
N01 · FY2019 · HD · contact PI
CCTN - CLINICAL EVALUATION OF LONG ACTING REVERSIBLE CONTRACEPTIVES$386,623
N01 · FY2015 · HD · contact PI